Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China · Delayed Price · Currency is CNY 42.17
-3.00 (-6.64%)
Oct 23, 2026, 10:55 AM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 16.76 billion as of October 22, 2026. It is the 5,660th most valuable company in the world and the 934th biggest in China. Its market cap has decreased by 46.71% in one year.
Market Cap
16.76B
Enterprise Value
16.58B
Revenue
4.02B
Global Rank
Country Rank
#934 China
PE Ratio
16.04
ChartMarket Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 16.76B, an increase of 16.71%. That is a compound annual growth rate of 2.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 16.76B | -50.93% |
| Dec 31, 2025 | 34.16B | 14.44% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Tiantan Biological Products | 24.20B |
| Hualan Biological Engineering | 23.72B |
| Hebei Changshan Biochemical Pharmaceutical | 17.97B |
| Yili Chuanning Biotechnology | 17.77B |
| Evopoint Biosciences | 16.67B |
| Acrobiosystems | 15.95B |
| Sinocelltech Group | 15.74B |
| HitGen | 14.88B |